Literature DB >> 9650562

Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.

M A Lyu1, Y K Choi, B N Park, B J Kim, I K Park, B H Hyun, Y H Kook.   

Abstract

Using chorio-allantoic membranes (CAMs) of chick embryos and severe-combined-immunodeficient (SCID) mice, we investigated the effects of urokinase-type plasminogen-activator receptor (u-PAR) over-expression on the process of invasion and tumorigenicity. By the transfection of u-PAR cDNA, 3 u-PAR-over-expressing clones expressing 1.6- to 4.6-fold more u-PAR mRNA than parent cells were obtained from a human epidermoid-carcinoma cell line, HEp3, that expresses urokinase-type plasminogen activator (u-PA) and u-PAR. All the u-PAR-over-expressing clones showed greater invasiveness (13 to 29%) than that of parent HEp3 cells on CAMs. Immunohistochemistry revealed densely stained u-PAR-positive cells near the margin of the tumor, where a u-PAR-over-expressing clone, designated SM-3, was invading thickened fibrous tissue on CAMs. Three u-PAR-overexpressing clones formed larger tumors (>40 mm3) than did parent HEp3 cells on CAMs. Moreover, when the u-PAR-overexpressing clone (SM-3) was injected s.c. into the back of the SCID mice it produced a larger tumor volume than the control (HEp3) and down-regulated (AS-2) clones and significantly shortened the survival of SCID mice. These results demonstrate that increased u-PAR expression is an important factor in determining the malignant phenotype that makes cancer cells more invasive and tumorigenic.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9650562     DOI: 10.1002/(sici)1097-0215(19980717)77:2<257::aid-ijc15>3.0.co;2-8

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Challenges for drug discovery - a case study of urokinase receptor inhibition.

Authors:  Zhuo Chen; Lin Lin; Qing Huai; Mingdong Huang
Journal:  Comb Chem High Throughput Screen       Date:  2009-12       Impact factor: 1.339

2.  Quantitative determination of tumor cell intravasation in a real-time polymerase chain reaction-based assay.

Authors:  Emilia Mira; Rosa Ana Lacalle; Concepción Gómez-Moutón; Esther Leonardo; Santos Mañes
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

3.  Synthesis, biological evaluation, and structure-activity relationships of novel substituted N-phenyl ureidobenzenesulfonate derivatives blocking cell cycle progression in S-phase and inducing DNA double-strand breaks.

Authors:  Vanessa Turcotte; Sébastien Fortin; Florence Vevey; Yan Coulombe; Jacques Lacroix; Marie-France Côté; Jean-Yves Masson; René C-Gaudreault
Journal:  J Med Chem       Date:  2012-06-21       Impact factor: 7.446

4.  Design, synthesis, biological evaluation, and structure-activity relationships of substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates as new tubulin inhibitors mimicking combretastatin A-4.

Authors:  Sébastien Fortin; Lianhu Wei; Emmanuel Moreau; Jacques Lacroix; Marie-France Côté; Eric Petitclerc; Lakshmi P Kotra; René C-Gaudreault
Journal:  J Med Chem       Date:  2011-06-13       Impact factor: 7.446

5.  A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with Murine Models for Early Evaluation of Cancer Therapy and Early Drug Toxicity.

Authors:  Tristan Rupp; Christophe Legrand; Marion Hunault; Laurie Genest; David Babin; Guillaume Froget; Vincent Castagné
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

6.  Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis.

Authors:  Noor A Lokman; Alison S F Elder; Carmela Ricciardelli; Martin K Oehler
Journal:  Int J Mol Sci       Date:  2012-08-10       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.